The rapidly expanding role of thermal ablation in the treatment of colorectal liver metastases

Martijn R. Meijerink, M. Petrousjka van den Tol, Robbert S. Puijk


According to last year’s status report on the global burden of cancer, colorectal carcinoma is a rising major medical concern with an estimated rate of over 1.8 million new patients and 881,000 cessations annually, making it the second main cause of cancer-related mortality worldwide (1). Of all colorectal cancer patients, 40–76% will develop colorectal liver metastases (CRLM) in the course of their disease (2-4).